Department of Gynecological Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
Department of Oncology, Shanghai Medical College, Fudan University, 270 Dong'an Road, Shanghai, 200032, China.
J Transl Med. 2024 Jun 18;22(1):577. doi: 10.1186/s12967-024-05236-1.
Inherited variations in DNA double-strand break (DSB) repair pathway are known to influence ovarian cancer occurrence, progression and treatment response. Despite its significance, survival-associated genetic variants within the DSB pathway remain underexplored.
In the present study, we performed a two-phase analysis of 19,290 single-nucleotide polymorphisms (SNPs) in 199 genes in the DSB repair pathway from a genome-wide association study (GWAS) dataset and explored their associations with overall survival (OS) in 1039 Han Chinese epithelial ovarian carcinoma (EOC) patients. After utilizing multivariate Cox regression analysis with bayesian false-discovery probability for multiple test correction, significant genetic variations were identified and subsequently underwent functional prediction and validation.
We discovered a significant association between poor overall survival and the functional variant GEN1 rs56070363 C > T (CT + TT vs. TT, adjusted hazard ratio (HR) = 2.50, P < 0.001). And the impact of GEN1 rs56070363 C > T on survival was attributed to its reduced binding affinity to hsa-miR-1287-5p and the resultant upregulation of GEN1 mRNA expression. Overexpression of GEN1 aggregated EOC cell proliferation, invasion and migration presumably by influencing the expression of immune inhibitory factors, thereby elevating the proportion of polymorphonuclear myeloid-derived suppressor cells (PMN-MDSCs) and then constructing an immunosuppressive tumor microenvironment.
In conclusion, GEN1 rs56070363 variant could serve as a potential predictive biomarker and chemotherapeutic target for improving the survival of EOC patients.
已知 DNA 双链断裂 (DSB) 修复途径中的遗传变异会影响卵巢癌的发生、进展和治疗反应。尽管其意义重大,但 DSB 途径中与生存相关的遗传变异仍未得到充分探索。
在本研究中,我们对来自全基因组关联研究 (GWAS) 数据集的 DSB 修复途径中的 199 个基因中的 19290 个单核苷酸多态性 (SNP) 进行了两阶段分析,并探讨了它们与 1039 名汉族上皮性卵巢癌 (EOC) 患者的总生存期 (OS) 的关联。在利用多变量 Cox 回归分析和贝叶斯虚假发现概率进行多重检验校正后,确定了显著的遗传变异,随后进行了功能预测和验证。
我们发现,功能变异 GEN1 rs56070363 C > T (CT + TT 与 TT,调整后的危险比 (HR) = 2.50,P < 0.001) 与总体生存率差之间存在显著关联。并且 GEN1 rs56070363 C > T 对生存的影响归因于其与 hsa-miR-1287-5p 的结合亲和力降低,以及 GEN1 mRNA 表达的上调。GEN1 的过表达促进了 EOC 细胞的增殖、侵袭和迁移,可能是通过影响免疫抑制因子的表达,从而增加多形核髓样来源抑制细胞 (PMN-MDSCs) 的比例,进而构建免疫抑制性肿瘤微环境。
总之,GEN1 rs56070363 变体可以作为潜在的预测生物标志物和化疗靶点,以提高 EOC 患者的生存率。